Lupin gains on US FDA nod for Renvela generic - Business News Today

Monday, December 27, 2021

Lupin gains on US FDA nod for Renvela generic

Lupin rose 1.55% to Rs 911.10 after the company said that it has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) Sevelamer Carbonate for oral suspension.

from General News https://ift.tt/3EvKpzp

No comments:

Post a Comment

Sensex, Nifty hit day's high; realty stocks advance

The domestic equity benchmarks further extended gains and hit fresh intraday high in mid afternoon trade. The Nifty hovered around the 17,25...